Will earlier diagnosis of HIV infection in late presenters reduce the frequency of serious opportunistic infections?

HIV Medicine

Volumn 12, Issue 7, 2011, Pages 449-450

  Scourfield, A ^a   Jackson, A ^a   Nelson, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; VIRUS RNA;

ADULT; AGED; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CRYPTOCOCCAL MENINGITIS; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LETTER; MALE; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOXOPLASMOSIS; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; EARLY DIAGNOSIS; HIV INFECTIONS; HUMANS;

EID: 79959920297     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00931.x     Document Type: Letter

References (2)

1. Waters L, Fisher M, Anderson J et al. for the UK CHIC Steering Committee. Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med 2011; 12: 289-298.
2. Mocroft A, Reiss P, Kirk O et al. for the Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200cells/microL? Clin Infect Dis 2010; 51: 611-619. Erratum in: Clin Infect Dis 2010; 51: 1114.